The American Medical Association recently released its comments on the DEA's proposed rules for controlled substance prescribing via telemedicine. Many telehealth providers are supportive of the organization's recommendations, such as its suggestion to extend the timeframe patients have to refill their buprenorphine prescription after their initial supply is prescribed via telemedicine.
At this year's Vive from Nashville, Nicholas Turos, PharmD of Babson Diagnostics details how the BetterWay blood testing is designed to improve the overall process for the customer.
Fixing the mental health crisis is a long journey, but the first step is addressing the lack of resources and affordable access available to BIPOC and underserved communities, as well as the long-term implications that lack of services have on those patients.
The creation of consistent and high value engagements with individuals across their digital and in-person engagements will enable these providers to both attract and retain consumers in the rapidly evolving healthcare ecosystem.
Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company's Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid.
No comments